veractamycin A: from Actinomaduro sp. [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 3086408 |
| MeSH ID | M0460031 |
| Synonym |
|---|
| 95078-68-5 |
| pd-114,759 |
| pd 114759 |
| pd 114,759 |
| veractamycin a |
| antibiotic pd 114,759 |
| DTXSID40915129 |
| methyl 2,6-dideoxy-3-o-{2-[(1-hydroxy-2-methoxyprop-2-en-1-ylidene)amino]-4,5-dimethoxybenzoyl}hexopyranoside--methyl 2,6-dideoxy-4-s-methyl-4-thiohexopyranoside (1/2) |
| [(2s,3r,4s)-3-hydroxy-6-methoxy-2-methyloxan-4-yl] 4,5-dimethoxy-2-(2-methoxyprop-2-enoylamino)benzoate;(2s,3r,4r,6r)-6-methoxy-2-methyl-3-methylsulfanyloxan-4-ol;(2s,3r,4r,6s)-6-methoxy-2-methyl-3-methylsulfanyloxan-4-ol |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 5 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.66) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 5 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||